Arabic Arabic English English French French German German
dark

INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors

Dr. Dansey, Seagen’s Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development
Appointment of industry leader in drug development expands the Board’s diverse industry, clinical development, research and commercialization expertise Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

FDA Issues Final Master Protocols Guidance for COVID-19 Drugs and Vaccines

Next Post

PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

Related Posts
Total
0
Share